All ProductsDisplaying Products Alphabetically by Name (C)
| Cat. No. | Product Name / Activity |
|---|---|
| 3581 | C 021 dihydrochloride |
| Potent CCR4 antagonist | |
| 8007 | C 101248 |
| Selective and potent inhibitor of both mouse and human THIK-1 | |
| 7040 | C 176 |
| mSTING antagonist | |
| 2489 | C 75 |
| Potent fatty acid synthase inhibitor; proapoptotic | |
| 5821 | C-DIM 12 |
| Nurr1 activator; inhibits NF-κB-dependent gene expression | |
| 7273 | C-Laurdan |
| Two-photon polarity-sensitive lipid membrane probe. Used for: cell membrane imaging. Application: One and Two-photon microscopy for membrane Polarity | |
| 3520 | C-type natriuretic peptide (1-22) (human, rat, swine) |
| Endogenous peptide agonist at NPR2 | |
| 5382 | C16 |
| PKR inhibitor | |
| 7715 | C25-140 |
| TRAF6-Ubc13 interaction inhibitor | |
| 7692 | C26-A6 |
| Disrupts MTDH and SND1 interaction, enhances immune surveillance | |
| 7546 | C28 |
| Potent LMTK3 inhibitor | |
| 5373 | C34 |
| TLR4 inhibitor | |
| 4863 | CA 074 |
| Selective cathepsin B inhibitor | |
| 8105 | CAF 382 |
| Potent and selective CDKL5 inhibitor | |
| 7457 | CAM 833 |
| Selective orthosteric inhibitor of the BRCA2-RAD51 interaction | |
| 3337 | CART (55-102) (rat) |
| Neuromodulatory neuropeptide fragment; satiety factor | |
| 5050 | CASIN |
| Cdc42 inhibitor | |
| 5903 | CATPB |
| FFA2 (GPR43) inverse agonist | |
| 7379 | CB 5083 |
| Potent p97 ATPase inhibitor | |
| 2663 | CB 65 |
| High affinity, selective CB2 agonist | |
| 7591 | CB 839 |
| Potent glutaminase GLS1 inhibitor | |
| 6724 | CBA |
| Selective TRPM4 blocker | |
| 6319 | CBM 301940 |
| Potent malonyl-CoA decarboxylase inhibitor; orally bioavailable | |
| 7890 | CBMR 0083 |
| Potent allosteric FFA1 (GPR40) and 4 (GPR120) agonist | |
| 7018 | CBR-470-1 |
| PGK1 inhibitor; activates Nrf2 | |
| 6258 | CC 401 dihydrochloride |
| High affinity JNK inhibitor; also inhibits HCMV replication | |
| 5236 | CC4 |
| High affinity and subtype-selective α6β2 and α4β2 nAChR partial agonist | |
| 0452 | CCCP |
| Oxidative phosphorylation uncoupler | |
| 0333 | L-CCG-l |
| Potent group II mGlu agonist | |
| 1166 | CCK Octapeptide, sulfated |
| C-terminal octapeptide of CCK | |
| 3837 | CCMI |
| Positive allosteric modulator of α7 nAChRs | |
| 2435 | CCT 018159 |
| Hsp90 inhibitor | |
| 4968 | CCT 241533 dihydrochloride |
| Potent Chk2 inhibitor | |
| 4546 | rac-CCT 250863 |
| Potent Nek2 inhibitor | |
| 7799 | CCT 369260 |
| Molecular glue; induces degradation of BCL6 | |
| 2554 | CD 1530 |
| Potent and selective RARγ agonist | |
| 3824 | CD 2314 |
| Selective RARβ agonist | |
| 3800 | CD 2665 |
| Selective RARβ/γ antagonist | |
| 3302 | CD 3254 |
| Potent and selective RXRα agonist | |
| 1549 | CD 437 |
| RARγ-selective agonist | |
| 6391 | CD38 inhibitor 78c |
| Potent CD38 inhibitor; active in vivo | |
| 4737 | CDDO Im |
| Nrf2 signaling activator | |
| 7372 | CDK8/19i |
| Potent and selective CDK8 and CDK19 inhibitor; maintains pluripotency of mouse PSCs in culture | |
| 5869 | CDN 1163 |
| SERCA2 allosteric activator | |
| 3235 | CDPPB |
| Positive allosteric modulator of mGlu5 receptors | |
| 4793 | CE3F4 |
| Noncompetitive Epac1 inhibitor | |
| 5969 | (R)-CE3F4 |
| Epac inhibitor; R-enantiomer of CE3F4 (Cat. No. 4793) | |
| 7952 | CELT-133 |
| Selective hα1A adrenergic receptor fluorescent antagonist | |
| 7953 | CELT-211 |
| Fluorescent serotonin 5HT2B receptor ligand for HTS | |
| 7954 | CELT-327 |
| Potent and selective hA2B/A3 adenosine receptor fluorescent antagonist | |
| 7955 | CELT-426 |
| Potent and partially selective hD2 dopamine receptor fluorescent antagonist | |
| 8108 | CEP |
| Chemoproteomic reagent, clickable electrophilic purine for RNA binding profiling in live cells | |
| 4924 | CEP 1347 |
| Inhibitor of JNK signaling | |
| 7991 | CEPT Cocktail Kit |
| Cell culture supplement for improving stem cell survival | |
| 3430 | CFTRinh 172 |
| Voltage-independent, selective CFTR chloride channel blocker | |
| 7425 | CG 428 |
| Potent tropomyosin receptor kinase (TRK) Degrader | |
| 7426 | CG 428-Neg |
| Negative control for CG 428 (Cat. No. 7425) | |
| 7427 | CG 858 |
| Selective BRAF-V600E protein Degrader (uSMITE™) | |
| 7428 | CG 858-Neg |
| Negative control for CG 858 (Cat. No. 7427) | |
| 6965 | CGI 1746 |
| Potent, reversible BTK inhibitor | |
| 2639 | CGK 733 |
| Induces apoptosis in prematurely senescent cells | |
| 1134 | CGP 12177 hydrochloride |
| β3 partial agonist. β1/β2 antagonist | |
| 1024 | CGP 20712 dihydrochloride |
| Highly potent and selective β1 antagonist | |
| 2966 | CGP 3466B maleate |
| GAPDH inhibitor; neuroprotective | |
| 1245 | CGP 35348 |
| Selective GABAB antagonist; brain penetrant | |
| 3219 | CGP 36216 hydrochloride |
| GABAB antagonist; displays activity at presynaptic receptors | |
| 1114 | CGP 37157 |
| Antagonist of mitochondrial Na+/Ca2+ exchange | |
| 1469 | CGP 37849 |
| Potent and selective NMDA antagonist | |
| 2569 | CGP 42112 |
| Selective, high affinity AT2 ligand | |
| 1247 | CGP 46381 |
| Selective GABAB antagonist; brain penetrant | |
| 1246 | CGP 52432 |
| Potent and selective GABAB antagonist | |
| 2442 | CGP 53353 |
| Selective inhibitor of PKCβII | |
| 1088 | CGP 54626 hydrochloride |
| Potent and selective GABAB antagonist | |
| 1248 | CGP 55845 hydrochloride |
| Potent and selective GABAB antagonist | |
| 2731 | CGP 57380 |
| Selective inhibitor of Mnk1 | |
| 5471 | CGP 60474 |
| Potent cdk inhibitor | |
| 2199 | CGP 71683 hydrochloride |
| Highly selective and potent non-peptide NPY Y5 receptor antagonist | |
| 5472 | CGP 74514 dihydrochloride |
| Potent CDK1 inhibitor | |
| 1493 | CGP 78608 hydrochloride |
| Potent and selective NMDA antagonist; acts at glycine site | |
| 1513 | CGP 7930 |
| Positive allosteric modulator of GABAB receptors | |
| 3012 | α-CGRP (human) |
| CGRP agonist | |
| 1161 | CGRP (rat) |
| Potent vasodilator | |
| 1181 | CGRP 8-37 (human) |
| CGRP antagonist | |
| 1169 | CGRP 8-37 (rat) |
| CGRP antagonist | |
| 0638 | CGS 12066B dimaleate |
| 5-HT1B agonist | |
| 1699 | CGS 15943 |
| Potent adenosine receptor antagonist | |
| 1241 | CGS 19755 |
| Potent competitive NMDA antagonist | |
| 1063 | CGS 21680 hydrochloride |
| A2A agonist | |
| 2512 | CGS 35066 |
| Endothelin-converting enzyme (ECE) inhibitor | |
| 2255 | CGS 9343B |
| Calmodulin antagonist | |
| 3858 | CH 223191 |
| Potent aryl hydrocarbon receptor (AhR) antagonist | |
| 5029 | CHC |
| MCT inhibitor; decreases glycoloysis | |
| 6725 | CHDI 00390576 |
| Potent and selective class IIa HDAC inhibitor; brain penetrant | |
| 7879 | CHDI 00484077 |
| Potent and selective HDAC class IIa inhibitor | |
| 8063 | CHDI 113 |
| Potent HTT pre-RNA splicing modulator | |
| 8044 | CHIPOpt New |
| CHIP/STUB1 E3 ligase inhibitor | |
| 6695 | CHIR 98014 |
| Highly potent and selective GSK-3 inhibitor | |
| TB4423-GMP | CHIR 99021 |
| CHIR 99021 synthesized to cGMP guidelines | |
| 4953 | CHIR 99021 trihydrochloride |
| Hydrochloride salt of CHIR 99021 (Cat. No. 4423); selective GSK-3 inhibitor | |
| 8170 | CHIR 99021 in solution New |
| Sterile-filtered 10 mM solution of CHIR 99021 pre-dissolved in DMSO | |
| 1049 | CHPG |
| mGlu5 selective agonist | |
| 3695 | CHPG Sodium salt |
| Selective mGlu5 agonist; sodium salt of CHPG (Cat. No. 1049) | |
| 3595 | CHR 2797 |
| Aminopeptidase inhibitor | |
| 5326 | CHR 6494 trifluoroacetate |
| Potent and selective haspin inhibitor | |
| 6753 | CHS 828 |
| NAMPT inhibitor; active in vivo and cytotoxic | |
| 1296 | CI 966 hydrochloride |
| Selective inhibitor of GAT-1 | |
| 2227 | CI 976 |
| Selective ACAT inhibitor | |
| 2607 | CI 988 |
| Potent and selective CCK2 antagonist | |
| 7494 | CIA 1 |
| COUP-TFII inhibitor | |
| 6544 | CID 1375606 |
| GPR27 agonist | |
| 4959 | CID 16020046 |
| Selective GPR55 antagonist | |
| 4293 | CID 2745687 |
| GPR35 antagonist | |
| 3327 | CID 755673 |
| Selective protein kinase D inhibitor | |
| 5521 | CIM 0216 |
| Selective TRPM3 agonist | |
| 7812 | CIMBA hydrochloride |
| Potent and selective G protein-coupled estrogen receptor (GPER) antagonist | |
| 4105 | CIQ |
| Potentiator of NMDA receptors containing GluN2C/GluN2D | |
| 3683 | CITCO |
| Selective CAR agonist | |
| 7811 | CITFA |
| Potent G protein-coupled estrogen receptor (GPER) agonist | |
| 3950 | CK 666 |
| Arp2/3 inhibitor; inhibits actin polymerization | |
| 5329 | CKI 7 dihydrochloride |
| CK1 inhibitor | |
| 1499 | CL 316243 disodium salt |
| Highly selective β3 agonist | |
| 2632 | CL 82198 hydrochloride |
| Selective inhibitor of MMP-13 | |
| 5582 | TAT-cyclo-CLLFVY |
| Selective HIF-1 dimerization inhibitor | |
| 5242 | CLP 257 |
| Selective KCC2 activator | |
| 6758 | CLP 290 |
| K+/Cl- cotransporter 2 (KCC2) activator; orally bioavailable prodrug of CLP 257 (Cat. No.5242) | |
| 6416 | CM 11 |
| Homo-PROTAC® for self-degradation of pVHL30 | |
| 6677 | CMA |
| Murine-selective STING agonist | |
| 2186 | CMPD-1 |
| Selective inhibitor of p38α-mediated MK2a phosphorylation; also tubulin polymerization inhibitor | |
| 5642 | CMPD101 |
| Potent and selective GRK2/3 inhibitor | |
| 5963 | CMPI hydrochloride |
| Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs | |
| 4642 | 4-CMTB |
| FFA2 agonist; also exhibits positive allosteric modulatory activity | |
| 0190 | CNQX |
| Potent and selective non-NMDA iGluR antagonist | |
| 1045 | CNQX disodium salt |
| Potent non-NMDA iGluR antagonist; more water soluble form of CNQX (Cat. No. 0190) | |
| 6354 | CNV Dopamine |
| Caged dopamine; photolysed by UV light | |
| 3405 | COG 133 |
| ApoE peptide fragment | |
| 5320 | CORM 3 |
| Water-soluble carbon monoxide-releasing molecule | |
| 4193 | CP 100356 hydrochloride |
| P-gp inhibitor | |
| 3649 | CP 122721 hydrochloride |
| High affinity NK1 antagonist | |
| 2779 | CP 154526 |
| Selective, non-peptide CRF1 antagonist | |
| 3542 | CP 316819 |
| Selective glycogen phosphorylase inhibitor | |
| 3212 | CP 376395 hydrochloride |
| Potent and selective CRF1 antagonist; binds at an allosteric site | |
| 6558 | CP 43 |
| Potent TAOK inhibitor | |
| 2932 | CP 465022 hydrochloride |
| Selective and non-competitive AMPA antagonist | |
| 5993 | CP 673451 |
| Potent and selective PDGFR inhibitor | |
| 4556 | CP 690550 citrate |
| Potent JAK inhibitor | |
| 4190 | CP 775146 |
| Selective, high affinity PPARα agonist | |
| 3041 | CP 809101 hydrochloride |
| Potent and selective 5-HT2C agonist | |
| 1032 | CP 93129 dihydrochloride |
| 5-HT1B agonist | |
| 1317 | CP 94253 hydrochloride |
| Potent and selective 5-HT1B agonist | |
| 4236 | CP 945598 hydrochloride |
| CB1 antagonist | |
| 2893 | CP 96345 |
| Potent and selective NK1 antagonist | |
| 3417 | CP 99994 dihydrochloride |
| High affinity NK1 antagonist | |
| 1028 | CPCCOEt |
| Selective non-competitive mGlu1 antagonist | |
| 5331 | CPI 203 |
| BET bromodomain inhibitor; arrests cell cycle at G1 phase | |
| 0247 | (R)-CPP |
| Potent NMDA antagonist; more active enantiomer of (RS)-CPP | |
| 0173 | (RS)-CPP |
| Potent NMDA antagonist | |
| 0972 | CPPG |
| Potent group III mGlu antagonist | |
| 1265 | D-CPP-ene |
| Potent competitive NMDA antagonist | |
| 7800 | CPS2 |
| Potent and selective CDK2 Degrader (PROTAC®) | |
| 4400 | (±)-CPSI 1306 |
| Reported macrophage migration inhibitory factor (MIF) inhibitor | |
| 2688 | CPT 11 |
| DNA topoisomerase I inhibitor; antitumor | |
| 1645 | 8-CPT-2Me-cAMP, sodium salt |
| Selective Epac activator | |
| 4568 | CPYPP |
| DOCK2-Rac1 interaction inhibitor | |
| 3605 | (R)-CR8 |
| Cdk inhibitor; potently inhibits cdk1 and cdk2; also inhibits CK1; acts as molecular glue | |
| 4803 | CRANAD 2 |
| Near-infrared probe that detects Aβ40 aggregates. Used for: amyloid-β detection in vitro and in vivo. Application: fluorescence microscopy, epifluorescence microscopy | |
| 7219 | CRBN PROTAC® 14a |
| Cereblon Degrader (PROTAC®) | |
| 6948 | CRBN-6-5-5-VHL |
| Potent and selective cereblon Degrader (PROTAC®); cell-permeable | |
| 1151 | CRF (human, rat) |
| Stimulates ACTH release | |
| 5479 | CRID3 sodium salt |
| Potent NLRP3 inflammasome inhibitor; inhibits IL-1β production | |
| 4975 | CRT 0066101 |
| Potent protein kinase D (PKD) inhibitor | |
| 5922 | CRT 0066854 hydrochloride |
| PKCι and PKCζ inhibitor | |
| 6273 | CRT 0105950 |
| Potent LIMK1/2 inhibitor | |
| 4543 | CS 2100 |
| Selective S1P1 agonist | |
| 7982 | CS 640 |
| Potent CaM kinase I inhibitor | |
| 7089 | CSN5i-3 |
| Potent and selective CSN5 (COP9 signalosome) inhibitor | |
| 7532 | CSN5i-3-NEG |
| Negative control for CSN5i-3 (Cat. No. 7089) | |
| 8066 | CST 530, Phenol |
| Functionalized IAP ligand for PROTACs® | |
| 8021 | CST 626 |
| Potent pan IAP Degrader (PROTAC®) | |
| 7745 | CST 905 |
| Potent and selective BRAFV600E Degrader (PROTAC®) | |
| 7801 | CST 967 |
| Potent and selective USP7 Degrader (PROTAC®) | |
| 4726 | CTA 056 |
| ITK inhibitor | |
| 1560 | CTAP |
| Potent and selective μ antagonist | |
| 5130 | CTCE 9908 |
| CXCR4 antagonist; antitumor | |
| 1578 | CTOP |
| Potent and selective μ antagonist | |
| 7794 | CTPI 2 |
| Selective mitochondrial citrate transporter (SLC25A1) inhibitor | |
| 4884 | CU CPT 22 |
| Selective TLR1/2 inhibitor | |
| 4883 | CU CPT 4a |
| Selective TLR3 inhibitor | |
| 6479 | CU CPT 9a |
| Highly potent TLR8 inhibitor | |
| 7820 | CU-76 |
| Selective inhibitor of cyclic GMP-AMP synthase (cGAS) | |
| 5414 | CU-T12-9 |
| Potent TLR1/2 agonist | |
| 5164 | CVT 10216 |
| Potent and selective ALDH2 inhibitor | |
| 6174 | CVT 313 |
| Cdk2 and cdk5 inhibitor | |
| 5495 | CW 008 |
| PKA signaling activator; promotes osteogenesis from hMSCs | |
| 6144 | CX08005 |
| Competitive PTP1B inhibitor | |
| 2980 | CX 546 |
| AMPA potentiator | |
| 5149 | CX 614 |
| Positive allosteric modulator of AMPA receptors | |
| 6436 | CY 09 |
| NLRP3 inhibitor; active in vivo | |
| 1249 | CY 208-243 |
| Selective D1-like agonist | |
| 4677 | CYM 50260 |
| Potent and selective S1P4 agonist | |
| 4678 | CYM 50308 |
| Potent and selective S1P4 agonist | |
| 4679 | CYM 50358 hydrochloride |
| Potent and selective S1P4 antagonist | |
| 4948 | CYM 50769 |
| Novel non-peptide NPBWR1 antagonist | |
| 3601 | CYM 5442 hydrochloride |
| Selective S1P1 receptor agonist | |
| 5418 | CYM 5520 |
| Selective S1P2 allosteric agonist | |
| 4897 | CYM 5541 |
| Selective S1P3 receptor allosteric agonist | |
| 4606 | CYM 9484 |
| Potent NPY Y2 receptor antagonist | |
| 1843 | CYN 154806 |
| Selective sst2 antagonist | |
| 6071 | CZC 25146 |
| Potent LRRK2 inhibitor | |
| 4877 | CaCCinh-A01 |
| Calcium-activated chloride channel (CaCC) inhibitor | |
| 2664 | Cabergoline |
| D2-like agonist (D2>D3>D4) | |
| 6264 | Caerulein |
| CCK agonist | |
| 2743 | Caffeic acid phenethyl ester |
| Specific inhibitor of NF-κB activation | |
| 1935 | Caffeic acid-pYEEIE |
| Phosphopeptide ligand for src SH2 domain | |
| 2793 | Caffeine |
| A1 and A2B antagonist. CNS stimulant | |
| 7181 | Caffeine Orange |
| Selective, BODIPY-based fluorescent caffeine chemosensor | |
| 5119 | Calcein AM |
| Cell permeable non-fluorescent compound; green-fluorescent in living cells once hydrolyzed. Used for: cell tracing and cell viability monitoring. Application: fluorescent microscopy and flow cytometry | |
| 2700 | Calcipotriol |
| Vitamin D3 analog | |
| 6031 | Calcitonin (human) |
| Endogenous calcitonin agonist; inhibits bone resorption | |
| 1159 | Calcitonin (salmon) |
| Affects bone formation and resorption | |
| 2551 | Calcitriol |
| Vitamin D receptor (VDR) agonist | |
| 4387 | Calhex 231 hydrochloride |
| Negative allosteric modulator of calcium-sensing receptor (CaSR) | |
| 2561 | Calmidazolium chloride |
| Calmodulin antagonist | |
| 1626 | Calphostin C |
| Potent, selective and photo-dependent PKC inhibitor | |
| 1336 | Calyculin A |
| Protein phosphatase 1 and 2A inhibitor | |
| 7137 | Cambinol |
| nSMase2 inhibitor | |
| 3193 | Camostat mesylate |
| Orally active protease inhibitor; inhibits entry of SARS-Cov-2 into lung cells | |
| 1100 | Camptothecin |
| DNA topoisomerase inhibitor | |
| 4791 | Candesartan |
| AT1 antagonist | |
| 5916 | Canertinib dihydrochloride |
| Potent EGFR kinase inhibitor | |
| 1570 | (-)-Cannabidiol |
| Natural cannabinoid; GPR55 antagonist, weak CB1 antagonist, CB2 inverse agonist and AMT inhibitor | |
| 3021 | Cannabigerol |
| Cannabinoid receptor partial agonist | |
| 0462 | (E)-Capsaicin |
| TRPV agonist | |
| 0464 | Capsazepine |
| TRPV antagonist; also activator of ENaCδ | |
| 6781 | Capzimin dimer |
| Selective proteasome inhibitor | |
| 4098 | Carbamazepine |
| Inhibitor of neuronal NaV channels; anticonvulsant | |
| 2810 | Carbamoylcholine chloride |
| Non-selective cholinergic agonist | |
| 3096 | Carbenoxolone disodium |
| Gap junction blocker. Also inhibitor of 11 β-hydroxysteroid dehydrogenase | |
| 4852 | Carbetocin |
| Oxytocin analog | |
| 0455 | (S)-(-)-Carbidopa |
| Aromatic L-amino acid decarboxylase inhibitor | |
| 2626 | Carboplatin |
| DNA cross-linking antitumor agent | |
| 0458 | 5-Carboxamidotryptamine maleate |
| 5-HT1 agonist; also has high affinity for 5-ht5a and 5-HT7 | |
| 0323 | (S)-4-Carboxyphenylglycine |
| Competitive group I mGlu antagonist; also weak group II agonist | |
| 2509 | Cardamonin |
| Inhibitor of NF-κB activation; anti-inflammatory | |
| 7188 | Carfilzomib |
| Potent irreversible proteasome inhibitor; active in vivo | |
| 5358 | Cariporide |
| Selective NHE1 inhibitor; cardioprotective and antitumor | |
| 2685 | Carvedilol |
| Potent and non-selective β antagonist; also potent α1 antagonist | |
| 7139 | CeMMEC1 |
| TAF1 inhibitor | |
| 6955 | Ceapin A7 |
| Selective inhibitor of ATF6α; sensitizes cells to ER stress | |
| 7454 | Cediranib |
| Potent inhibitor of VEGFR, PDGFR and FGFR | |
| 5867 | Ceefourin 1 |
| Selective MRP4 inhibitor | |
| 3203 | Celastrol |
| Inhibits TNF-α-induced NF-κB activation | |
| 3786 | Celecoxib |
| Selective cyclooxygenase-2 (COX-2) inhibitor | |
| 5476 | Cell Activation Cocktail 500X |
| Cell activation cocktail | |
| 7368 | Cell Counting Kit-8 |
| Cell viability and proliferation assay test solution | |
| 5687 | Centrinone |
| High affinity and selective PLK4 inhibitor | |
| 5690 | Centrinone B |
| High affinity and selective PLK4 inhibitor | |
| 0744 | Ceramide |
| Ser/Thr protein phosphatase activator | |
| 4448 | Ceranib 1 |
| Ceramidase inhibitor; antiproliferative | |
| 4500 | Cercosporamide |
| Potent Mnk2 inhibitor | |
| 4492 | Cerestat |
| Potent and noncompetitive NMDA antagonist | |
| 6905 | Ceritinib |
| Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3 | |
| 3536 | Cetrorelix Acetate |
| Potent GnRH receptor antagonist | |
| 3689 | Cevimeline hydrochloride |
| Selective M1 agonist | |
| 2020 | Ch 55 |
| Potent RAR agonist | |
| 4504 | Chaetocin |
| SUV39H1 inhibitor | |
| 1330 | Chelerythrine chloride |
| Cell-permeable protein kinase C inhibitor | |
| 7769 | Chem-CLIP control probe |
| Control probe for Chem-CLIP experiments | |
| 7116 | Chemerin-9, Human |
| Potent CMKLR1 agonist; c-terminal peptide of full length human chemerin | |
| 7117 | Chemerin-9, Mouse |
| Potent CMKLR1 agonist; c-terminal peptide of full length mouse chemerin | |
| 0456 | Chlormezanone |
| Positive allosteric modulator of benzodiazepine site | |
| 1705 | 2-Chloro-N6-cyclopentyladenosine |
| Potent and selective A1 agonist | |
| 3136 | 2-Chloroadenosine |
| Adenosine receptor agonist | |
| 4436 | 8-Chloroadenosine |
| Cytotoxic nucleoside analog; inhibits RNA synthesis | |
| 3697 | 7-Chlorokynurenic acid sodium salt |
| Potent competitive inhibitor of L-glutamate uptake. Sodium salt of 7-Chlorokynurenic acid (Cat. No. 0237) | |
| 0237 | 7-Chlorokynurenic acid |
| Potent competitive inhibitor of L-glutamate uptake | |
| 0938 | p-Chlorophenylalanine |
| Tryptophan hydroxylase inhibitor | |
| 0440 | m-Chlorophenylbiguanide hydrochloride |
| Potent and selective 5-HT3 agonist | |
| 0442 | 4-Chlorophenylguanidine hydrochloride |
| Urokinase inhibitor | |
| 4109 | Chloroquine diphosphate |
| Antimalarial; inhibits apoptosis and autophagy | |
| 7945 | Cholesterol |
| Component of lipid nanoparticles (LNPs); modulator of lipid bilayer fluidity | |
| 7163 | Chroman 1 |
| Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogenesis | |
| 1412 | Chromanol 293B |
| IKs blocker. Also blocks ICFTR | |
| 1475 | (-)-[3R,4S]-Chromanol 293B |
| IKs blocker. Enantiomer of Chromanol 293B (Cat. No. 1412) | |
| 6357 | Ciclesonide |
| Glucocorticoid antiasthmatic prodrug | |
| 6384 | Ciclopirox |
| Pan-histone demethylase inhibitor | |
| 5870 | Cilengitide |
| Potent and selective inhibitor of integrins αvβ3 and αvβ5 | |
| 4529 | Ciliobrevin A |
| Hedgehog (Hh) pathway antagonist, inhibits ciliogenesis; also inhibits dynein | |
| 2629 | Cilnidipine |
| Dual CaV1.x and CaV2.x blocker | |
| 0915 | Cilostamide |
| PDE3 inhibitor | |
| 1692 | Cilostazol |
| PDE3A inhibitor. Also adenosine uptake inhibitor | |
| 0902 | Cimetidine |
| H2 antagonist, I1 agonist | |
| 6170 | Cinacalcet hydrochloride |
| Allosteric Calcium-sensing receptor (CaSR) agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable | |
| 0460 | Cinanserin hydrochloride |
| Selective 5-HT2 antagonist; also 3C-like proteinase inhibitor | |
| 0888 | Cirazoline hydrochloride |
| Selective α1 agonist | |
| 1695 | Cisapride |
| 5-HT4 agonist; stimulates intestinal ACh release | |
| 2251 | Cisplatin |
| Potent pro-apoptotic anticancer agent; activates caspase-3 | |
| 1427 | Citalopram hydrobromide |
| Highly potent and selective 5-HT uptake inhibitor | |
| 5763 | (R)-Citalopram oxalate |
| Enantiomer of escitalopram oxalate (Cat. No. 1427) | |
| 3812 | Cl-4AS-1 |
| Steroidal androgen receptor agonist | |
| 6321 | 10-Cl-BBQ |
| Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable | |
| 1104 | 2-Cl-IB-MECA |
| Highly selective A3 agonist | |
| 5292 | Cladribine |
| Deoxyadenosine analog; pro-apoptotic | |
| 1453 | Clemastine fumarate |
| H1 antagonist | |
| 6798 | Click N-Acetylmuramic acid - alkyne |
| Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
| 7506 | Click N-Acetylmuramic acid - azide |
| Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
| 0752 | Clobenpropit dihydrobromide |
| Highly potent H3 antagonist and H4 partial agonist | |
| 0898 | Clocinnamox mesylate |
| Irreversible μ antagonist | |
| 2600 | Clofarabine |
| Deoxycytidine kinase (dCK) substrate | |
| 0690 | Clonidine hydrochloride |
| α2 agonist. Also I1 ligand | |
| 1820 | (+)-Clopidogrel hydrogen sulfate |
| Selective P2Y12 antagonist | |
| 2490 | (±)-Clopidogrel hydrochloride |
| Selective P2Y12 antagonist | |
| 4096 | Clotrimazole |
| Cytochrome P450 inhibitor; antifungal | |
| 0444 | Clozapine |
| Dopamine antagonist with some D4 selectivity; also 5-HT2A/2C antagonist | |
| 4936 | Clozapine N-oxide |
| Activator of hM3Dq and hM4Di DREADDs | |
| 6329 | Clozapine N-oxide dihydrochloride |
| Activator of hM3Dq and hM4Di DREADDs; water soluble version of Clozapine N-oxide (Cat. No. 4936) | |
| 2456 | Co 101244 hydrochloride |
| GluN2B-selective NMDA antagonist | |
| 1364 | Colchicine |
| Inhibitor of tubulin | |
| 3945 | Colivelin |
| STAT3 activator; also protects against β-amyloid neurotoxicity | |
| 6476 | Compound E |
| γ-secretase inhibitor; induces neuronal differentiation | |
| 2585 | Compstatin |
| C3-binding peptide; inhibits complement activation | |
| 3796 | Compstatin control peptide |
| Control peptide for Compstatin (Cat. No. 2585) | |
| 2656 | Concanamycin A |
| H+-ATPase (vacuolar) inhibitor | |
| 7056 | Conduritol B epoxide |
| Irreversible glucocerebrosidase (β-glucosidase) inhibitor; used to generate Gaucher disease models | |
| 6830 | Conivaptan hydrochloride |
| Very high affinity vasopressin V1A and V2 antagonist; orally bioavailable | |
| 1085 | ω-Conotoxin GVIA |
| CaV2.2 blocker | |
| 7920 | CoraFluor™ 1, amine reactive |
| Terbium cryptate FRET donor for TR-FRET assay development; amine reactive for conjugation | |
| 8117 | CoraFluor™ 1, thiol reactive New |
| Terbium cryptate FRET donor for TR-FRET assay development, cysteine reactive for conjugation | |
| 7950 | CoraFluor™ 2, amine reactive |
| Terbium cryptate FRET donor for TR-FRET assay development; amine reactive for conjugation | |
| 2294 | Cordycepin |
| RNA synthesis inhibitor | |
| 3685 | Corticosterone |
| Endogenous glucocorticoid | |
| 3374 | Cortistatin 14 |
| Endogenous neuropeptide; binds sst1 - sst5, ghrelin receptor and MRGPRX2 | |
| 7485 | Covidcil-19 |
| Binds to SARS-CoV-2 frameshifting element and reduces frameshifting efficiency | |
| 4368 | Crizotinib |
| Potent c-MET/ALK inhibitor | |
| 6025 | (S)-Crizotinib |
| MTH1 inhibitor | |
| 1571 | Cucurbitacin I |
| Selective inhibitor of STAT3/JAK2 signaling | |
| 7394 | Cy5B-trisulfo, NHS |
| Restricted conformation cyanine dye with high quantum yield and long fluorescence lifetime for advanced microscopy applications | |
| 2953 | CyPPA |
| KCa2.2 and KCa2.3 (SK) channel activator | |
| 6457 | Cyanine 3 Tyramide |
| Orange fluorescent reagent widely used for signal amplification in IHC and FISH | |
| 6458 | Cyanine 5 Tyramide |
| Red fluorescent reagent widely used for signal amplification in IHC and FISH | |
| 5436 | Cyanine 5, SE |
| Red fluorescent dye (Reactive group: NHS ester). Application: confocal microscopy, fluorescence microscopy, flow cytometry | |
| 0993 | Cyanopindolol hemifumarate |
| 5-HT1A and 5-HT1B antagonist; also β-adrenergic antagonist | |
| 3180 | α-Cyclodextrin |
| Cyclic complexing agent | |
| 3181 | β-Cyclodextrin |
| Cyclic complexing agent | |
| 0970 | Cycloheximide |
| Inhibitor of protein synthesis | |
| 1623 | Cyclopamine |
| Inhibitor of Hedgehog (Hh) signaling | |
| 6137 | 8-Cyclopentyl-1,3-dimethylxanthine |
| High affinity adenosine A1 receptor antagonist | |
| 1702 | N6-Cyclopentyladenosine |
| Potent and selective A1 agonist | |
| 4091 | Cyclophosphamide |
| Alkylating agent; chemotherapeutic | |
| 1235 | Cyclopiazonic acid |
| Inhibitor of SERCA ATPase | |
| 3493 | Cyclosomatostatin |
| Non-selective sst antagonist | |
| 1101 | Cyclosporin A |
| Calcineurin inhibitor | |
| 6982 | Cyclosporin H |
| Enhances lentiviral transduction | |
| 0713 | Cyclothiazide |
| Positive allosteric modulator of AMPA receptors; inhibits AMPA desensitization | |
| 5062 | Cyclotraxin B |
| TrkB receptor antagonist | |
| 2601 | Cyprodime hydrochloride |
| Selective μ antagonist | |
| 7337 | Cysmethynil |
| ICMT inhibitor; arrests cell-cycle at G1 phase | |
| 4520 | Cytarabine |
| Nucleoside analog; inhibits DNA replication | |
| 1390 | (-)-Cytisine |
| Potent and selective neuronal nAChRagonist | |
| 5474 | Cytochalasin B |
| Inhibitor of actin polymerization | |
| 1233 | Cytochalasin D |
| Disrupts actin filament function | |
| 5459 | Cytosporone B |
| High affinity Nur77 agonist |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800